AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cartesian Therapeutics, Inc. Director's Dealing 2019

Aug 16, 2019

33483_dirs_2019-08-16_539c07bf-360f-4f9d-bf4b-42f346c83a40.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-11-10

Reporting Person: SPRINGER TIMOTHY A (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1237028	Indirect
Common Stock	445576	Indirect

Footnotes

F1: These shares were omitted from the Reporting Person's original Form 4 filed on March 29, 2019.

F2: LKST, Inc. is the general partner of Leukon Investments LP. Timothy Springer is the president of LKST, Inc. and the managing member of TAS Partners, LLC. The Reporting Person disclaims beneficial ownership of the securities held by Leukon Investments LP and TAS Partners, LLC except to the extent of his pecuniary interest therein, if any.

F3: Held by Leukon Investments LP.

F4: Held by TAS Partners, LLC.